JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bushnell, P. J.
Right arrow Articles by Olszyk, V. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bushnell, P. J.
Right arrow Articles by Olszyk, V. B.

Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate

PJ Bushnell, SS Padilla, T Ward, CN Pope and VB Olszyk

Neurotoxicology Division, United States Environmental Protection Agency, Research Triangle Park, North Carolina.

Behavioral effects of organophosphates (OPs) typically decrease with repeated exposure, despite persistence of OP-induced inhibition of acetylcholinesterase (AChE) and downregulation of muscarinic acetylcholine (ACh) receptors. To characterize this tolerance phenomenon, rats were trained to perform an appetitive operant task which allowed daily quantification of working memory (accuracy of delayed matching-to-position), reference memory (accuracy of visual discrimination) and motor function (choice response latencies and inter- response times during delay). Daily s.c. injections of 0.2 mg/kg of diisopropylfluorophosphate (DFP) caused no visible cholinergic signs, did not affect body weight or visual discrimination, but progressively impaired matching accuracy and lengthened response latencies and interresponse times. These effects recovered in seven of eight treated rats after termination of DFP treatment. Resumption of daily DFP at 0.1 mg/kg caused smaller impairments of both matching accuracy and response latency. After 21 injections of 0.2 mg/kg/day of DFP, rats were subsensitive to the hypothermia induced by acute oxotremorine (0.2 mg/kg i.p.), as expected after OP-induced downregulation of muscarinic ACh receptors. Evidence for supersensitivity to scopolamine (0.03 and 0.056 mg/kg i.p.) in DFP-treated rats was mixed, with additive effects predominating on both the cognitive and motor aspects of the task. After 18 days of 0.1 mg/kg of DFP, AChE was inhibited 50 to 75% and muscarinic ACh receptor density was reduced 15 to 20% in hippocampus and frontal cortex. Progressive declines in AChE activity in hippocampus and frontal cortex across 15 daily doses with DFP at 0.1 and 0.2 mg/kg were observed in other rats; quinuclidinyl benzilate binding was significantly reduced in hippocampus after 15 doses at both levels of DFP. These results indicate that animals showing a definitive sign of tolerance to OP administration (subsensitivity to a cholinergic agonist) were also functionally impaired on both the mnemonic and motoric demands of a working memory task. The nature of this impairment suggests further that it results from compensatory changes in the central nervous system, e.g., muscarinic receptor downregulation, considered to produce "tolerance" to OPs in exposed animals.

Volume 256, Issue 2, pp. 741-750, 02/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Toxicol SciHome page
V. C. Moser, P. M. Phillips, K. L. McDaniel, R. S. Marshall, D. L. Hunter, and S. Padilla
Neurobehavioral Effects of Chronic Dietary and Repeated High-Level Spike Exposure to Chlorpyrifos in Rats
Toxicol. Sci., August 1, 2005; 86(2): 375 - 386.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
F. Canadas, D. Cardona, E. Davila, and F. Sanchez-Santed
Long-Term Neurotoxicity of Chlorpyrifos: Spatial Learning Impairment on Repeated Acquisition in a Water Maze
Toxicol. Sci., June 1, 2005; 85(2): 944 - 951.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. J. Lein and A. D. Fryer
Organophosphorus Insecticides Induce Airway Hyperreactivity by Decreasing Neuronal M2 Muscarinic Receptor Function Independent of Acetylcholinesterase Inhibition
Toxicol. Sci., January 1, 2005; 83(1): 166 - 176.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. Ankarberg, A. Fredriksson, and P. Eriksson
Increased Susceptibility to Adult Paraoxon Exposure in Mice Neonatally Exposed to Nicotine
Toxicol. Sci., December 1, 2004; 82(2): 555 - 561.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Fayuk and J. L. Yakel
Regulation of Nicotinic Acetylcholine Receptor Channel Function by Acetylcholinesterase Inhibitors in Rat Hippocampal CA1 Interneurons
Mol. Pharmacol., September 1, 2004; 66(3): 658 - 666.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. D. Fryer, P. J. Lein, A. S. Howard, B. L. Yost, R. A. Beckles, and D. A. Jett
Mechanisms of organophosphate insecticide-induced airway hyperreactivity
Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L963 - L969.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Cohn and R. C. Macphail
Chlorpyrifos Produces Selective Learning Deficits in Rats Working Under a Schedule of Repeated Acquisition and Performance
J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 312 - 320.
[Abstract] [Full Text]


Home page
Hum Exp ToxicolHome page
H. Schulz, L. Nagymajtenyi, and I. Desi
Life-time exposure to dichlorvos affects behaviour of mature rats
Human and Experimental Toxicology, September 1, 1995; 14(9): 721 - 726.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics.